Loading...
AbbVie Inc.
4AB.DU•DUS
HealthcareMedical - Pharmaceuticals
€166.20
€2.20(1.34%)
AbbVie Inc. (4AB.DU) Financial Performance & Statements
Review AbbVie Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
3.71%
↑ 3.71%
Operating Income Growth
-28.38%
↓ 28.38%
Net Income Growth
-12.03%
↓ 12.03%
Operating Cash Flow Growth
-17.66%
↓ 17.66%
Operating Margin
17.56%
↑ 17.56%
Gross Margin
70.69%
↑ 70.69%
Net Profit Margin
7.31%
↑ 7.31%
ROE
95.59%
↑ 95.59%
ROIC
10.10%
↑ 10.10%
AbbVie Inc. (4AB.DU) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for AbbVie Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $15.10B | $14.46B | $14.46B | $12.31B |
| Cost of Revenue | $4.40B | $4.21B | $2.18B | $4.08B |
| Gross Profit | $10.71B | $10.25B | $12.29B | $8.23B |
| Gross Profit Ratio | $0.71 | $0.71 | $0.85 | $0.67 |
| R&D Expenses | $6.77B | $2.13B | $1.92B | $1.94B |
| SG&A Expenses | $3.85B | $4.21B | $3.34B | $3.30B |
| Operating Expenses | $12.20B | $6.42B | $7.21B | $5.24B |
| Total Costs & Expenses | $16.59B | $10.63B | $10.46B | $9.51B |
| Interest Income | $92.00M | $0.00 | $220.00M | $207.00M |
| Interest Expense | $702.00M | $591.00M | $726.00M | $660.00M |
| Depreciation & Amortization | $2.10B | $2.08B | $2.13B | $2.07B |
| EBITDA | $535.00M | $4.93B | $7.13B | $5.56B |
| EBITDA Ratio | $0.04 | $0.34 | $0.49 | $0.45 |
| Operating Income | -$1.49B | $3.83B | $4.00B | $2.80B |
| Operating Income Ratio | -$0.10 | $0.26 | $0.28 | $0.23 |
| Other Income/Expenses (Net) | -$779.00M | -$1.75B | -$1.85B | -$1.04B |
| Income Before Tax | -$2.27B | $2.08B | $2.15B | $1.75B |
| Income Before Tax Ratio | -$0.15 | $0.14 | $0.15 | $0.14 |
| Income Tax Expense | -$2.25B | $520.00M | $773.00M | $383.00M |
| Net Income | -$22.00M | $1.56B | $1.37B | $1.37B |
| Net Income Ratio | -$0.001 | $0.11 | $0.09 | $0.11 |
| EPS | -$0.02 | $0.88 | $0.78 | $0.77 |
| Diluted EPS | -$0.02 | $0.88 | $0.78 | $0.77 |
| Weighted Avg Shares Outstanding | $1.77B | $1.77B | $1.77B | $1.77B |
| Weighted Avg Shares Outstanding (Diluted) | $1.77B | $1.77B | $1.77B | $1.77B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan